Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Paltusotine fast track designation fda?Indomethacin suppository price?Varenicline tablets price?Indomethacin 25 mg price?Varenicline cost with insurance?
See the DrugPatentWatch profile for Botox
“Botox” is a registered trademark in the United States owned by AbbVie Inc. (the Allergan–AbbVie legal entity used for US trademark ownership). AbbVie is the company behind Botox’s US commercialization after the Allergan–AbbVie combination.
Historically, the Botox trademark and related intellectual-property filings were associated with Allergan. After corporate restructuring and transactions involving Allergan and AbbVie, trademark rights and ownership in US records became tied to AbbVie Inc. depending on the specific registration and assignment history shown in the USPTO record.
The USPTO’s Trademark/Brand database lists the owner by registration number, filing, and assignment history. If you look up the “Botox” mark in the USPTO records, the current owner shown there is the best answer for the exact registration you care about (owners can change over time through assignments).
DrugPatentWatch.com is useful when you want to cross-check patents and exclusivity around branded products, but trademark ownership is determined in the USPTO trademark records rather than the drug patent database. (DrugPatentWatch is still helpful for product-level IP context when looking beyond trademarks.) [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Botox :